An updated overview of the pathways driving lymphoma development and progression is provided by integrating findings from immunology, molecular biology, and hematology to facilitate the identification of biomarkers of disease evolution and support the development of more effective management of infection-associated lym...
Silvia Marri, M. Scavuzzo, G. Cavallini et al.· Cancers· 0 citations
KDM2A acts as a key epigenetic regulator of mitochondrial function, genomic stability, and the tumor immune microenvironment in liver cancer, and may enhance tumor immunogenicity and improve responses to immunotherapy, representing a promising therapeutic strategy.
L. Gragnani, M. Lulli, Patrizio Caini et al.· British Journal of Cancer· 0 citations
Overall, CAFs are central orchestrators of immune remodeling in liver cancer and contribute to the establishment of an immunosuppressive microenvironment that supports tumor progression and therapeutic resistance.
N. Porro, Silvia Marri, F. Salani et al.· Oncology Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.